Article info
Editorial
Ticagrelor and the prevention of cardiovascular mortality: more than just platelet inhibition?
- Correspondence to Dr Michael A Gaglia Jr, Division of Cardiovascular Medicine, University of Southern California Keck School of Medicine, 1510 San Pablo St., HCC I, Suite 322, Los Angeles, CA 91030, USA; mgaglia{at}usc.edu
Citation
Ticagrelor and the prevention of cardiovascular mortality: more than just platelet inhibition?
Publication history
- Received June 26, 2014
- Revised July 6, 2014
- Accepted July 7, 2014
- First published July 23, 2014.
Online issue publication
October 19, 2014
Article Versions
- Previous version (23 July 2014).
- Previous version (3 August 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions